Overview
Michelle Monje is a Pediatric Neurologist and a Neurologist in Palo Alto, California. Dr. Monje is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. Her top areas of expertise are Diffuse Midline Glioma H3 K27M-Mutant, Brain Stem Cancer, Glioma, and Gliomatosis Cerebri.
Her clinical research consists of co-authoring 166 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Neurotoxicity Syndromes.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Stanford Health Care
Brian Scott is a Neurologist in Stanford, California. Dr. Scott is rated as a Distinguished provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Neurotoxicity Syndromes, Miller-Fisher Syndrome, Chronic Polyradiculoneuritis, and Guillain-Barre Syndrome.
Edgardo Alicaway is a Neurologist in Daly City, California. Dr. Alicaway is rated as an Advanced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Unverricht-Lundborg Syndrome, Lafora Disease, Progressive Myoclonic Epilepsy, and Dravet Syndrome.
Stanford Health Care
Carl Gold is a Neurologist in Stanford, California. Dr. Gold is rated as an Advanced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Encephalitis, Meningitis, Guillain-Barre Syndrome, and Seizures.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Brain Stem CancerDr. Monje isElite. Learn about Brain Stem Cancer.
- Brain TumorDr. Monje isElite. Learn about Brain Tumor.
- Diffuse Midline Glioma H3 K27M-Mutant
- GliomaDr. Monje isElite. Learn about Glioma.
- Gliomatosis CerebriDr. Monje isElite. Learn about Gliomatosis Cerebri.
- Distinguished
- Posterior Fossa TumorDr. Monje isDistinguished. Learn about Posterior Fossa Tumor.
- Advanced
- AstrocytomaDr. Monje isAdvanced. Learn about Astrocytoma.
- Choroid Plexus PapillomaDr. Monje isAdvanced. Learn about Choroid Plexus Papilloma.
- Embryonal Tumor with Multilayered Rosettes
- GlioblastomaDr. Monje isAdvanced. Learn about Glioblastoma.
- MedulloblastomaDr. Monje isAdvanced. Learn about Medulloblastoma.
- Optic GliomaDr. Monje isAdvanced. Learn about Optic Glioma.
- Experienced
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- CACH SyndromeDr. Monje isExperienced. Learn about CACH Syndrome.
- EncephalitisDr. Monje isExperienced. Learn about Encephalitis.
- EpendymomaDr. Monje isExperienced. Learn about Ependymoma.
- EpilepsyDr. Monje isExperienced. Learn about Epilepsy.
- Epilepsy Juvenile AbsenceDr. Monje isExperienced. Learn about Epilepsy Juvenile Absence.